AbbVie Inc has agreed to pay US$24 million to settle a lawsuit that alleged insurance fraud by the drugmaker in promoting its blockbuster drug Humira, California’s insurance regulator said on Thursday.
AbbVie agrees to pay US$24 million to resolve Humira California lawsuit
